Suppression of Pentosidine Formation in Galactosemic Rat Lens by an Inhibitor of Aldose Reductase

Recent work from our laboratory revealed a correlation between the degree of protein pigmentation in human cataractous lens and the advanced Maillard reaction as reflected by pentosidine formation. Although the data suggested a role for ascorbate in pentosidine formation in senile cataractous lenses, elevated pentosidine levels in diabetic cataracts suggested that glucosylation may be involved directly in pentosidine biosynthesis. To clarify this issue, we quantified pentosidine in lenses from rats with experimental galactosemia with and without aldose reductase inhibitor treatment. At 12 months, pentosidine-like fluorescence (335/385 nm) was three to six times higher (P < 0.0001) in water soluble and insoluble crystallins of galactosemic compared with nongalactosemic rats. Actual pentosidine levels increased shortly after onset of galactosemia. Contents in water-insoluble crystallins were 6.32 ± 2.2 and 1.40 ± 0.66 pmol/mg protein in galactosemic and control lenses, respectively (P < 0.001). Fluorescence and pentosidine were suppressed to almost control levels upon treatment with sorbinil. Incubation experiments showed that pentosidine could form slowly from galactose, but much more rapidly from ascorbate and its oxidation products. Its formation could be inhibited partly by both reduced and oxidized glutathione or ε-aminocaproic acid. The requirement of oxygen for pentosidine formation suggests that oxidative stress associated with glutathione depletion and ascorbate oxidation are plausible mechanisms for rapid pentosidine formation upon onset of galactosemia. In contrast, Maillard reaction by glycoxidation products may account for the sustained increase in pentosidine. Both these events may be linked to the newly recognized pseudohypoxic state of cells exposed to high sugar concentrations.

[1]  R. E. Perry,et al.  Progressive changes in lens crystallin glycation and high-molecular-weight aggregate formation leading to cataract development in streptozotocin-diabetic rats. , 1987, Experimental eye research.

[2]  K. Bensch,et al.  The role of ascorbic acid in senile cataract. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[3]  V. Monnier,et al.  Chromatographic Quantitation of Plasma and Erythrocyte Pentosidine in Diabetic and Uremic Subjects , 1992, Diabetes.

[4]  A. Swaak,et al.  Iron mobilization from ferritin by superoxide derived from stimulated polymorphonuclear leukocytes. Possible mechanism in inflammation diseases. , 1984, The Journal of clinical investigation.

[5]  P. Mclean,et al.  The Effect of an Aldose Reductase Inhibitor (Sorbinil) on the Level of Metabolites in Lenses of Diabetic Rats , 1983, Diabetes.

[6]  T. Lyons,et al.  Role of Glycation in Modification of Lens Crystallins in Diabetic and Nondiabetic Senile Cataracts , 1991, Diabetes.

[7]  S. Som,et al.  Ascorbic acid metabolism in diabetes mellitus. , 1981, Metabolism: clinical and experimental.

[8]  R. Blakytny,et al.  Glycation (non-enzymic glycosylation) inactivates glutathione reductase. , 1992, The Biochemical journal.

[9]  V. J. Stevens,et al.  Diabetic cataract formation: potential role of glycosylation of lens crystallins. , 1978, Proceedings of the National Academy of Sciences of the United States of America.

[10]  J. Kinoshita,et al.  Aldose reductase in diabetic cataracts. , 1981, JAMA.

[11]  V. Reddy,et al.  Glutathione and its function in the lens--an overview. , 1990, Experimental eye research.

[12]  A. Tappel,et al.  Inactivation of ribonuclease and other enzymes by peroxidizing lipids and by malonaldehyde. , 1969, Biochemistry.

[13]  D. Dvornik,et al.  Polyol Accumulation in Galactosemic and Diabetic Rats: Control by an Aldose Reductase Inhibitor , 1973, Science.

[14]  A. Beyer-Mears,et al.  Reversal of Diabetic Cataract by Sorbinil, an Aldose Reductase Inhibitor , 1985, Diabetes.

[15]  S. Srivastava,et al.  The transport of oxidized glutathione from human erythrocytes. , 1969, The Journal of biological chemistry.

[16]  E. Abraham,et al.  Glycation of human lens proteins: Preferential glycation of αA subunits☆ , 1992 .

[17]  M. Lou,et al.  Glutathione depletion in the lens of galactosemic and diabetic rats. , 1988, Experimental eye research.

[18]  J. Kinoshita,et al.  Sorbitol pathway in diabetic and galactosemic rat lens , 1974 .

[19]  C. Waydhas,et al.  Glutathione efflux from perfused rat liver after phenobarbital treatment, during drug oxidations, and in selenium deficiency. , 1978, European journal of biochemistry.

[20]  L. Chylack,et al.  Role of nonenzymatic glycosylation in experimental cataract formation. , 1980, Biochemical and biophysical research communications.

[21]  B. Ortwerth,et al.  Glutathione inhibits the glycation and crosslinking of lens proteins by ascorbic acid. , 1988, Experimental eye research.

[22]  V. J. Stevens,et al.  Nonenzymatic glycosylation, sulfhydryl oxidation, and aggregation of lens proteins in experimental sugar cataracts , 1979, The Journal of experimental medicine.

[23]  B. S. Winkler,et al.  In vitro oxidation of ascorbic acid and its prevention by GSH. , 1987, Biochimica et biophysica acta.

[24]  J. Baynes,et al.  Formation of pentosidine during nonenzymatic browning of proteins by glucose. Identification of glucose and other carbohydrates as possible precursors of pentosidine in vivo. , 1991, The Journal of biological chemistry.

[25]  A. Meister,et al.  Inhibition of glutathione synthesis in the newborn rat: a model for endogenously produced oxidative stress. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[26]  T. Kuwabara,et al.  Galactose cataract prevention with sorbinil, an aldose reductase inhibitor: a light microscopic study. , 1982, Investigative ophthalmology & visual science.

[27]  B. Ortwerth,et al.  The glycation-associated crosslinking of lens proteins by ascorbic acid is not mediated by oxygen free radicals. , 1991, Experimental eye research.

[28]  H. Kern,et al.  Transport of vitamin C in the lens. , 1987, Current eye research.

[29]  V. Monnier,et al.  Non-tryptophan fluorescence and high molecular weight protein formation in lens crystallins of rats with chronic galactosemia: prevention by the aldose reductase inhibitor sorbinil. , 1990, Experimental eye research.

[30]  V. Monnier,et al.  High correlation between pentosidine protein crosslinks and pigmentation implicates ascorbate oxidation in human lens senescence and cataractogenesis. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[31]  V. Monnier,et al.  Nonenzymatic browning in vivo: possible process for aging of long-lived proteins. , 1981, Science.

[32]  J. Eaton,et al.  Spirohydantoin inhibitors of aldose reductase inhibit iron- and copper-catalysed ascorbate oxidation in vitro. , 1991, Biochemical pharmacology.

[33]  V. Monnier,et al.  Mechanism of formation of the Maillard protein cross-link pentosidine. Glucose, fructose, and ascorbate as pentosidine precursors. , 1991, The Journal of biological chemistry.

[34]  R. Dean,et al.  Hydroxyl radical production and autoxidative glycosylation. Glucose autoxidation as the cause of protein damage in the experimental glycation model of diabetes mellitus and ageing. , 1988, The Biochemical journal.